Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis

Anne Fleur Louise Van Der Paardt, Onno W. Akkerman, Gina Gualano, Fabrizio Palmieri, Lina Davies Forsman, Alena Aleksa, Simon Tiberi, Wiel C.M. De Lange, Mathieu S. Bolhuis, Alena Skrahina, Dick Van Soolingen, Jos G.W. Kosterink, Giovanni Battista Migliori, Tjip S. Van Der Werf, Jan Willem C. Alffenaar

Research output: Contribution to journalLetter

Original languageEnglish
Article number1601612
JournalEuropean Respiratory Journal
Volume49
Issue number3
DOIs
Publication statusPublished - Mar 1 2017

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Van Der Paardt, A. F. L., Akkerman, O. W., Gualano, G., Palmieri, F., Forsman, L. D., Aleksa, A., Tiberi, S., De Lange, W. C. M., Bolhuis, M. S., Skrahina, A., Van Soolingen, D., Kosterink, J. G. W., Migliori, G. B., Van Der Werf, T. S., & Alffenaar, J. W. C. (2017). Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis. European Respiratory Journal, 49(3), [1601612]. https://doi.org/10.1183/13993003.01612-2016